Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous dexmedetomidine versus bupivacaine during hernia surgery
IRCT20141209020258N99Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of dexmedetomidine, bupivacaine and Normal Saline-Benha University in hernia (3 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Mean arterial blood pressure, Heart rate and 3 more. Started Aug 2018; status: completed.
02
Drugs
dexmedetomidinebupivacaineNormal Saline-Benha University
03
Conditions
hernia
Beyond the preview
Go deeper on IRCT20141209020258N99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N99.